Elicio Therapeutics Insider Trades

ELTX

Track insider trading activity from Elicio Therapeutics executives and directors. See which insiders are buying and selling ELTX stock.

Trades Last 12 Months

ELTX Price

All Insider Trades for Elicio Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Haqq Christopher See Remarks
Holding Value $852k 57,381 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$618k 76,300 shares
$8.10
$14.85
De Muth Peter Chief Scientific Officer
Holding Value $618k 41,600 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$337k 41,600 shares
$8.10
$14.85
Connelly Robert Ceo, President And Director
Holding Value $2.19M 147,200 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 220,800 shares
$8.10
$14.85
Shah Preetam See Remarks
Holding Value $711k 47,900 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 71,900 shares
$8.10
$14.85
Holding Value $1.53M 103,225 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$800k 103,225 shares
$7.75
$14.85
Wilson Karen J Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Ashe Carol Gail Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Nissenson Allen Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Ruffolo Robert R Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Venkatesan Jay Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Adams Julian Director
Holding Value $117k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$14.85
Demuth Peter Chief Scientific Officer
Holding Value $659k 44,400 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 44,400 shares
$8.92
$14.85
Piekos Brian Chief Financial Officer
Holding Value $642k 43,225 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 43,225 shares
$4.50
$14.85
Goldberg Itzhak Director
Holding Value $25.1M 1,687,986 shares
Last Trade
Jul 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.59M 32,082 shares
$112.00
$14.85
Omenn Gilbert S Director
Holding Value $223k 15,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6M 15,000 shares
$173.00
$14.85
Ganzi Victor F Director
Holding Value $223k 15,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6M 15,000 shares
$173.00
$14.85
Neylan John F. Executive Vice President, Chief Medical Officer And Head Of Research
Holding Value $4.08M 275,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.7M 275,000 shares
$199.00
$14.85
Rhodes Jennifer J Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer And Secretary
Holding Value $4.08M 275,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.7M 275,000 shares
$199.00
$14.85
Curhan Gregory S Chief Financial Officer
Holding Value $1.49M 100,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.9M 100,000 shares
$199.00
$14.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up